BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32059452)

  • 21. Nitric oxide-mediated cytoprotection of hepatocytes from glucose deprivation-induced cytotoxicity: involvement of heme oxygenase-1.
    Choi BM; Pae HO; Kim YM; Chung HT
    Hepatology; 2003 Apr; 37(4):810-23. PubMed ID: 12668974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory response to coronary artery bypass surgery: does the heme-oxygenase-1 gene microsatellite polymorphism play a role?
    Li P; Sanders J; Hawe E; Brull D; Montgomery H; Humphries S
    Chin Med J (Engl); 2005 Aug; 118(15):1285-90. PubMed ID: 16117883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of polymorphism within the heme oxygenase-I promoter on overall survival and transplantation-related mortality after allogeneic stem cell transplantation.
    Gerbitz A; Hillemanns P; Schmid C; Wilke A; Jayaraman R; Kolb HJ; Eissner G; Holler E
    Biol Blood Marrow Transplant; 2008 Oct; 14(10):1180-1189. PubMed ID: 18804049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting.
    Chen YH; Chau LY; Lin MW; Chen LC; Yo MH; Chen JW; Lin SJ
    Eur Heart J; 2004 Jan; 25(1):39-47. PubMed ID: 14683741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of heme oxygenase-1 gene rs2071746 polymorphism with vascular outcomes in patients with atherosclerotic stroke.
    Cao L; Zhang Z; Cai B; Bai W; Zhang Y; Sun W; Xie X; Sun W; Cai Q; Li Z; Liu D; Xiong Y; Ma M; Liu X; Xu G
    J Neurol Sci; 2014 Sep; 344(1-2):154-7. PubMed ID: 25016572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of heme oxygenase-1 in the antiproliferative and antiapoptotic effects of nitric oxide on Jurkat T cells.
    Pae HO; Choi BM; Oh GS; Lee MS; Ryu DG; Rhew HY; Kim YM; Chung HT
    Mol Pharmacol; 2004 Jul; 66(1):122-8. PubMed ID: 15213303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-like receptor 1 variation increases the risk of transplant-related mortality in hematologic malignancies.
    Uchino K; Mizuno S; Mizutani M; Horio T; Hanamura I; Espinoza JL; Matsuo K; Onizuka M; Kashiwase K; Morishima Y; Fukuda T; Kodera Y; Doki N; Miyamura K; Mori TM; Takami A;
    Transpl Immunol; 2016 Sep; 38():60-6. PubMed ID: 27369862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heme oxygenase 1: does it have a role in renal cytoprotection?
    Courtney AE; Maxwell AP
    Am J Kidney Dis; 2008 Apr; 51(4):678-90. PubMed ID: 18371544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The recipient's heme oxygenase-1 promoter region polymorphism is associated with cardiac allograft vasculopathy.
    Freystaetter K; Andreas M; Bilban M; Perkmann T; Kaider A; Masetti M; Kocher A; Wolzt M; Zuckermann A
    Transpl Int; 2017 May; 30(5):510-518. PubMed ID: 28186648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.
    Spitzer TR; McAfee S; Sackstein R; Colby C; Toh HC; Multani P; Saidman S; Weyouth DW; Preffer F; Poliquin C; Foley A; Cox B; Andrews D; Sachs DH; Sykes M
    Biol Blood Marrow Transplant; 2000; 6(3A):309-20. PubMed ID: 10905768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the influence of heme oxygenase 1 gene single nucleotide polymorphism (rs2071746) on esophageal varices among patients with cirrhosis.
    Ellakany WI; Mahmoud MoheyEldin K; Invernizzi P; Mahmoud ElKady A; Eldin Fathy Abou Elkheir H; Abdel Haleem Abo Elwafa R; Ellakany A
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):888-892. PubMed ID: 29877949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide.
    True AL; Olive M; Boehm M; San H; Westrick RJ; Raghavachari N; Xu X; Lynn EG; Sack MN; Munson PJ; Gladwin MT; Nabel EG
    Circ Res; 2007 Oct; 101(9):893-901. PubMed ID: 17885218
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients.
    Chen YH; Lin SJ; Lin MW; Tsai HL; Kuo SS; Chen JW; Charng MJ; Wu TC; Chen LC; Ding YA; Pan WH; Jou YS; Chau LY
    Hum Genet; 2002 Jul; 111(1):1-8. PubMed ID: 12136229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic bone marrow transplantation with matched unrelated donors for patients with hematologic malignancies using a preparative regimen of high-dose cyclophosphamide and fractionated total body irradiation.
    Geller RB; Devine SM; O'Toole K; Persons L; Keller J; Mauer D; Holland HK; Dix SP; Piotti M; Redei I; Connaghan G; Heffner LT; Hillyer CD; Waller EK; Winton EF; Wingard JR
    Bone Marrow Transplant; 1997 Aug; 20(3):219-25. PubMed ID: 9257890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heme oxygenase-1: a provenance for cytoprotective pathways in the kidney and other tissues.
    Nath KA
    Kidney Int; 2006 Aug; 70(3):432-43. PubMed ID: 16775600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heme oxygenase-1 expression in disease states.
    Deshane J; Wright M; Agarwal A
    Acta Biochim Pol; 2005; 52(2):273-84. PubMed ID: 15933765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A single-nucleotide polymorphism of the Fcγ receptor type IIIA gene in the recipient predicts transplant outcomes after HLA fully matched unrelated BMT for myeloid malignancies.
    Takami A; Espinoza JL; Onizuka M; Ishiyama K; Kawase T; Kanda Y; Sao H; Akiyama H; Miyamura K; Okamoto S; Inoue M; Ohtake S; Fukuda T; Morishima Y; Kodera Y; Nakao S;
    Bone Marrow Transplant; 2011 Feb; 46(2):238-43. PubMed ID: 20400988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Transplantation.
    Kanda Y; Kanda J; Atsuta Y; Maeda Y; Ichinohe T; Ohashi K; Fukuda T; Miyamura K; Iida H; Mori T; Iwato K; Eto T; Kawa K; Morita S; Morishima Y
    Br J Haematol; 2013 May; 161(4):566-77. PubMed ID: 23452319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.